Portfolio of Biotech Stocks: Second Portfolio

Here is a sample of 9 biotech stocks from the universe of biotechnology companies.

9 Biotech Stocks: Second Portfolio

& Monthly Returns

& Snapshot

Recent Prices
& Trendline Chart

Ionis PharmaceuticalsIONS
Madrigal PharmaceuticalsMDCL
Neurocrine BiosciencesNBIX
Sarepta TherapeuticsSRPT
Vanda PharmaceuticalsVNDA
Viking TherapueticsVKTX
Vir BiotechnologyVIR
Sparkline weekly price charts based on Alpha Vantage data.

9 Biotech Stocks: Second Portfolio

& Last 100 Days Returns


Last Close
& 100-Day Trendline Chart

Ionis PharmaceuticalsIONS$44.23
Madrigal PharmaceuticalsMDCL$1.02
Neurocrine BiosciencesNBIX$106.21
Sarepta TherapeuticsSRPT$110.54
Vanda PharmaceuticalsVNDA$9.88
Viking TherapueticsVKTX$2.72
Vir BiotechnologyVIR$19.28

Portfolio Values

To inspect the performance of the Biotech Stocks: Second Portfolio portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 8 stocks included in the portfolio computations are: ALKS, IONS, MDCL, NBIX, RGNX, SRPT, VNDA and VKTX. The current value of the portfolio assumes that $1,250.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. VIR was excluded from the portfolio computations because of insufficient price data.

The current value of the $10,000 investment is $11,587. The percent return is 15.87%. The annualized return is 2.99%.

8 Biotech Stocks: Second Portfolio Returns



Monthly Returns & Details

Ionis PharmaceuticalsIONS-12.76%
Madrigal PharmaceuticalsMDCL0.99%
Neurocrine BiosciencesNBIX73.32%
Sarepta TherapeuticsSRPT143.69%
Vanda PharmaceuticalsVNDA-44.80%
Viking TherapueticsVKTX42.41%

Portfolio Value Chart for Last 100 Daily Closes

Related Portfolios

Portfolio of Biotech Stock: First Portfolio

Portfolio of Biotech Stocks: Diabetes

Portfolio of Large Biotech Stocks